The venture arm of the US pharmaceuticals company run for nearly two decades, through large corporate shifts, because it manages to combine a focuses investment thesis with flexibility to the parent corporation's…
This is a summary
The full article is published by Global Venturing. We hold only a headline and a short summary here.
Read the full article